{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:13:04Z","timestamp":1780341184271,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["13GRNT16420015"],"award-info":[{"award-number":["13GRNT16420015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cardiovascularpathology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.carpath.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T17:51:09Z","timestamp":1473011469000},"page":"503-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Heart failure therapies: new strategies for old treatments and new treatments for old strategies"],"prefix":"10.1016","volume":"25","author":[{"given":"Marc K.","family":"Halushka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Padera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2016.08.008_bb0005","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Writing Group M","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCHEARTFAILURE.113.000807","article-title":"Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure","volume":"7","author":"Long","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.carpath.2016.08.008_bb0015","first-page":"1","volume":"17","author":"Sutcliffe","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.carpath.2016.08.008_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM198402023100501","article-title":"Clinical use of the total artificial heart","volume":"310","author":"DeVries","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJM198701153160303","article-title":"Temporary use of the Jarvik-7 total artificial heart before transplantation","volume":"316","author":"Griffith","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0030","first-page":"2102","article-title":"Options for temporary mechanical circulatory support","volume":"7","author":"Saffarzadeh","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.carpath.2016.08.008_bb0035","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1540-8191.2001.tb00521.x","article-title":"The Novacor left ventricular assist system: clinical experience from the Novacor registry","volume":"16","author":"Dagenais","year":"2001","journal-title":"J Card Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0045","first-page":"415","article-title":"Thoratec VAD system as a bridge to heart transplantation","volume":"9","author":"Farrar","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0050","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.healun.2004.08.024","article-title":"First clinical experience with the Incor left ventricular assist device","volume":"24","author":"Schmid","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.athoracsur.2011.09.021","article-title":"University of Maryland surgical experience with the Jarvik 2000 axial flow ventricular assist device","volume":"93","author":"Sorensen","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0065","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0070","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.healun.2015.03.001","article-title":"First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III)","volume":"34","author":"Schmitto","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.healun.2014.02.015","article-title":"Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS","volume":"33","author":"Saito","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa040186","article-title":"Cardiac replacement with a total artificial heart as a bridge to transplantation","volume":"351","author":"Copeland","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0085","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2015.10.024","article-title":"Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2016.03.026","article-title":"Outcomes on continuous flow left ventricular assist devices: a single institutional 9-year experience","author":"Morgan","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0095","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","article-title":"Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Jorde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.carpath.2006.04.008","article-title":"Infection in ventricular assist devices: the role of biofilm","volume":"15","author":"Padera","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.healun.2008.05.029","article-title":"Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device","volume":"27","author":"Mudd","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/TP.0b013e3182985371","article-title":"LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay","volume":"96","author":"Shankar","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mtc.2003.30","article-title":"Immunologic sensitization in recipients of left ventricular assist devices","volume":"125","author":"John","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1053-2498(01)00232-7","article-title":"Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival","volume":"20","author":"Pagani","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2016.05.001","article-title":"Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant","author":"Ko","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11886-013-0394-y","article-title":"INTERMACS and MedaMACS: how will they guide future therapy?","volume":"15","author":"Stewart","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.carpath.2016.08.008_bb0140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.healun.2014.09.015","article-title":"Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices","volume":"34","author":"Frazier","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/HCO.0b013e328345af13","article-title":"Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action","volume":"26","author":"Drakos","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.healun.2015.08.014","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report\u20142015; focus theme: early graft failure","volume":"34","author":"Yusen","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0155","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.clinthera.2015.08.019","article-title":"Latest developments in heart transplantation: a review","volume":"37","author":"Andrew","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.carpath.2016.08.008_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.trre.2015.02.005","article-title":"Immunosuppressive therapies after heart transplantation\u2014the balance between under- and over-immunosuppression","volume":"29","author":"Soderlund","year":"2015","journal-title":"Transplant Rev"},{"key":"10.1016\/j.carpath.2016.08.008_bb0165","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.athoracsur.2011.11.054","article-title":"Orthotopic heart transplantation in patients with metabolic risk factors","volume":"93","author":"Kilic","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR)","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.healun.2014.04.019","article-title":"A contemporary review of adult heart transplantation: 2012 to 2013","volume":"33","author":"DePasquale","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2007-0251","article-title":"Malignancy after solid organ transplantation: an overview","volume":"13","author":"Zafar","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.carpath.2016.08.008_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pathol.3.121806.151449","article-title":"Graft vascular disease: immune response meets the vessel wall","volume":"4","author":"Mitchell","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0190","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1600-6143.2006.01314.x","article-title":"Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy","volume":"6","author":"Mehra","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0195","first-page":"985","article-title":"Graft arteriosclerosis-induced myocardial pathology in heart transplant recipients: predictive value of endomyocardial biopsy","volume":"16","author":"Winters","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0200","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/j.1600-6143.2012.04223.x","article-title":"The future of heart transplantation","volume":"12","author":"Kobashigawa","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0205","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12265-015-9612-x","article-title":"Cardiac allograft vasculopathy: a donor or recipient induced pathology?","volume":"8","author":"van den Hoogen","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.carpath.2016.08.008_bb0215","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","article-title":"Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression","volume":"4","author":"Caforio","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.healun.2003.08.028","article-title":"De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system","volume":"23","author":"Rose","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0230","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0235","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0240","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.TP.0000061790.08550.EC","article-title":"High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease","volume":"75","author":"Bates","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0245","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1432-2277.2012.01484.x","article-title":"Phenotypes of antibody-mediated rejection in organ transplants","volume":"25","author":"Mengel","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.carpath.2016.08.008_bb0255","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1600-6143.2009.02588.x","article-title":"Outcomes of simultaneous heart-kidney transplant in the US: a retrospective analysis using OPTN\/UNOS data","volume":"9","author":"Gill","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0260","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.healun.2014.02.007","article-title":"Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study","volume":"33","author":"Guihaire","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5223(19)39805-8","article-title":"Diagnosis of human cardiac allograft rejection by serial cardiac biopsy","volume":"66","author":"Caves","year":"1973","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carpath.2016.08.008_bb0270","first-page":"277","article-title":"Histologic grading of cardiac allograft rejection: a quantitative approach","volume":"9","author":"McAllister","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0275","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0280","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0290","first-page":"63","article-title":"Complications of endomyocardial biopsy in heart transplant patients","volume":"12","author":"Baraldi-Junkins","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0295","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.healun.2006.10.003","article-title":"Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis","volume":"25","author":"Stehlik","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0300","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2012.03.015","article-title":"Usefulness of routine surveillance endomyocardial biopsy 6months after heart transplantation","volume":"31","author":"Orrego","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0305","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/bmm.14.56","article-title":"Biomarkers of acute rejection following cardiac transplantation","volume":"8","author":"McMinn","year":"2014","journal-title":"Biomark Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0310","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2016.08.008_bb0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.CIR.100.3.287","article-title":"Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans","volume":"100","author":"Masters","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0320","first-page":"704","article-title":"The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. The Journal of Heart and Lung Transplantation: the official publication of the International Society for Heart","volume":"28","author":"Kittleson","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.carpath.2016.08.008_bb0325","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.healun.2012.02.014","article-title":"Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejection","volume":"31","author":"Damodaran","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0335","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.healun.2009.04.025","article-title":"Whole blood genomic biomarkers of acute cardiac allograft rejection","volume":"28","author":"Lin","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0340","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0345","doi-asserted-by":"crossref","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.carpath.2016.08.008_bb0350","first-page":"430","article-title":"Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications","volume":"8","author":"Hammond","year":"1989","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0355","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.healun.2005.08.014","article-title":"Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies","volume":"24","author":"Hammond","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0360","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.healun.2009.10.016","article-title":"Controversies in defining cardiac antibody-mediated rejection: need for updated criteria","volume":"29","author":"Kfoury","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.carpath.2010.03.008","article-title":"Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies","volume":"20","author":"Kucirka","year":"2011","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0370","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0375","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.healun.2012.12.017","article-title":"Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection","volume":"32","author":"Fedrigo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0380","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.healun.2011.07.012","article-title":"Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation","volume":"30","author":"Fedrigo","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0385","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ajt.12162","article-title":"A survey of current practice for antibody-mediated rejection in heart transplantation","volume":"13","author":"Chih","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.carpath.2016.08.008_bb0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.carpath.2014.11.001","article-title":"Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies","volume":"24","author":"Frank","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2016.08.008_bb0395","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/ajt.12976","article-title":"Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP","volume":"15","author":"Fedrigo","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880716300503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880716300503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:35:26Z","timestamp":1601062526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880716300503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1054880716300503"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2016.08.008","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure therapies: new strategies for old treatments and new treatments for old strategies","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}